MR in Drug Research

Room A102
19:30 – 21:30

Business Meeting
  • Introduction
  • Future activities
  • Nominations for 2001 Governing Committee
  • Discussion
Scientific Meeting
  • Overview: Goals of the Study Group
    Thomas Ernst, Harbor-UCLA Medical Center, Torrance, CA, USA
  • FDA Research Initiatives in Safety Assessment
    David Lester, Food & Drug Administration, Rockville, MD, USA
  • The Industry Perspective
    Nicolau Beckmann, Novartis, Basel, Switzerland
  • The Investigator Perspective
    Perry Renshaw, McLean Hospital, Belmont, MA, USA
  • Discussion

Return to ISMRM program